Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Apr 21.
Published in final edited form as: J Am Chem Soc. 2021 Apr 8;143(15):5616–5621. doi: 10.1021/jacs.1c00885

Bioorthogonal retro-Cope elimination reaction of N,N-dialkylhydroxylamines and strained alkynes

Dahye Kang 1, Justin Kim 1
PMCID: PMC8483621  NIHMSID: NIHMS1741658  PMID: 33829777

Abstract

A bioorthogonal reaction between N,N-dialkylhydroxylamines and cyclooctynes is described. This reaction features a highly regioselective transformation between small, easily functionalizable reaction components with second order rate constants reaching 84 M−1s−1. The reaction is orthogonal to the inverse-electron demand Diels-Alder reactions between tetrazine and strained alkenes, and its components exhibit exquisite stability and chemoselectivity in cell lysate. This retro-Cope elimination reaction introduces a new member to the bioorthogonal reaction compendium outside the prolific class of cycloaddition reactions.

Graphical abstract

graphic file with name nihms-1741658-f0001.jpg


The growing compendium of bioorthogonal reactions has enabled the visualization, isolation, and manipulation of biomolecules in complex biological settings both in vitro and in vivo.1-3 These reactions have been instrumental in the study of primary and secondary metabolites such as proteins,1 sugars,4-6 and lipids7-9 as well as biomacromolecules10 whose modification by genetic means is neither practical nor possible. Demand continues to exist for additional bioorthogonal tools, particularly those that are more compact,11-12 rapid,13-15 stable,16-17 regioselective,18 functionally diverse,19-23 and orthogonal both to biology and to themselves.24-25 The development of new reactions making simultaneous advances along not just one or two, but several of these axes, is an enticing yet elusive aspiration.26-27

In search of bioorthogonal reactions, we deliberately explored transformations outside the well-studied class of cycloaddition reactions cognizant of the chemical properties that made these reactions effective. In particular, we contemplated whether other reactions might also engage with both carbons of a π-bond concertedly, circumventing the formation of a charged intermediate and the attendant need for significant polarization of the π-system that would render it susceptible to reaction by cellular nucleophiles. Modest asynchronicity in the transformation would, however, enable us to differentiate the two poles of the π-bond and deliver a regioselective transformation. The retro-Cope elimination reaction proved most serviceable (Figure 1).28-30 In this manuscript, we describe the bioorthogonal reaction of N,N-dialkyhydroxylamines and cyclooctynes to form stable enamine N-oxide ligation products in a rapid and regioselective manner with reaction components comprising as few as three non-hydrogen atoms.

Figure 1.

Figure 1.

Bioorthogonal retro-Cope elimination reaction between cyclooctynes and N,N-dialkylhydroxylamines.

We first evaluated the viability of the retro-Cope elimination reaction through density functional theory calculations31 and ascertained the activation barriers for the reaction of N,N-dimethylhydroxylamine with a variety of cyclooctynes (Figure 2A). Unmodified cyclooctyne itself proved promising with a calculated activation energy of 18.9 kcal/mol – sufficiently low for the reaction to proceed at room temperature. The absence of steric factors impinging on the incipient O··H··C2 bond in the transition state structure was equally noteworthy as it portended the importance that steric ambivalence toward propargylic substituents would have on the adaptability, mutual orthogonality, and reactivity of the cyclooctynes.

Figure 2.

Figure 2.

Computational studies of the retro-Cope elimination reaction between cyclooctynes (COT) and N,N-dimethylhydroxylamine. Geometries were optimized at the M06-2X/6-31G(d,p) level of theory and single point energies were computed at the M06-2X/6-311G(2d,p) level of theory. (A) Computational reaction model to evaluate the reactivity of cyclooctynes. (B) Calculated transition state structure and activation energy for cyclooctyne hydroamination. (C) Additional ring strain of bicyclo[6.1.0]nonyne results in a lower activation barrier. (D) Calculated free energies of activation (ΔG) as well as distortion (ΔEdist.) and interaction energies (ΔEint.) highlight the rapidity of the retro-Cope elimination reaction and the central role of hydroxylamine and alkyne distortion energies in lowering the activation barrier. R = p-NO2Ph.

Calculations of bicyclo[6.1.0]nonyne also tempered our initial expectations that additional strain could be harnessed to the same effect as for cycloaddition reactions (Figure 2C).32 Instead, we focused on the electronic modulation4, 33 of cyclooctyne, which proved more profound (Figure 2D). Further distortion/interaction energy analysis indicated a sizable reduction in distortion energy34-35 for the cyclooctynes versus their linear counterpart as expected, but unlike for cycloadditions, this reaction does not benefit from enhancement of interaction energy upon addition of electronegative substituents; the rate acceleration is driven by a decrease in the distortion energy of both components. The counterintuitive increase in the interaction energy is likely due to the reactant-ward shift of the transition state in accordance with Hammond’s postulate. Commensurate increases in the lengths of the C1··N and C2··H bonds further support this interpretation (see Supporting Information).

Kinetics experiments corroborated the reactivity trends predicted by computation. Using NMR spectroscopy to monitor reaction progress, we determined the second order rate constants for the reaction of N,N-diethylhydroxyl amine (1) with a panel of cyclooctynes 2–10 in d3-acetonitrile at room temperature (Figure 3). Cyclooctyne (2) proved remarkably reactive, displaying a second order rate constant of 3.25×10−2 M−1s−1 – an order of magnitude faster than its reaction with benzyl azide.36 Further strain enhancements provided a 6.7-fold rate acceleration as predicted for bicyclo[6.1.0]nonyne 3, but far from the 100-fold increase observed for analogous azide-alkyne cycloadditions.32 Still, the second order rate constant of 2.17×10−1 M−1s−1 compared favorably with the fastest azide-based reactions involving BARAC.13

Figure 3.

Figure 3.

Kinetics studies for the hydroamination of cyclooctynes 2–10 by N,N-diethylhydroxylamine (1). Second-order rate constants were obtained using a 1:1 ratio of cyclooctyne to hydroxylamine in CD3CN at rt. Measurements made in 50% H2O/CD3CN are in parentheses. The rate constant for difluorocyclooctyne 10 was derived from competition experiments with carbamate 9.

The hydroamination reaction of cyclooctynes was particularly sensitive to the inductive effects of propargylic substituents, and progressive rate enhancements were observed with increasing electronegativity (Figure 3). The most reactive of the cyclooctynol-derived substrates was carbamate 9 featuring a rate constant of 3.87 M−1s−1, a 120-fold improvement over that of cyclooctyne (2). Importantly, the minimalistic cyclooctyn-1-ol substructure proved versatile, being both easy to synthesize and derivatize; it was amenable to conjugation via an ester, carbamate, or a ketal linkage without incurring significant costs in size or reactivity. Indeed, elaborate functionalization of the core cyclooctyne was not only unnecessary, it at times proved deleterious. Reaction of N,N-diethylhydroxylamine with dibenzoazacyclooctyne 8 (DIBAC)37 was rapid, yet still inferior in reaction rate to carbamate 9 and not appreciably superior to its more austere counterparts. Notably, the ligation product of the dibenzoazacyclooctyne 8 plus N,N-diethylhydroxylamine was prone to degradation, being uniquely unstable to purification by both standard and reverse phase flash chromatography.

We surmised from prior reports that difluorocyclooctyne 10 operates at the limits of bioorthogonality4, 38 and would provide a reasonable upper bound on hydroamination kinetics that can be achieved using electronically-tuned cyclooctynes in biological settings. Astoundingly, a competition experiment with cyclooctyne 9 revealed its rate constant to be 83.6 M−1s−1 in CD3CN.

Notably, the retro-Cope elimination reaction is highly directed by substrate electronics and produced only a single observable regioisomer for cyclooctynes 2–7, 9, and 10. Accordingly, when a symmetrical N,N-dialkylhydroxylamine is employed, a single product is formed selectively.

To test the bioorthogonality of the hydroamination reaction, we performed in vitro protein labeling experiments. Fluorophore-conjugated hydroxylamine 13 was first assembled from 6-carboxytetramethylrhodamine and hydroxylamine 12, which was in turn synthesized by nucleophilic displacement of iodide 11 with N-methylhydroxylamine hydrochloride (Figure 4A). Separately, lysozyme was functionalized with cyclooctyne via N-hydroxysuccinimide ester 14 (Figure 4B). With both reaction components in hand, cyclooctyne-functionalized lysozyme 15 was treated with hydroxylamine 13 (0–200 μM) in PBS for 2 h and analyzed by in-gel fluorescence (Figure 4C). Labeling occurred in a concentration-dependent manner as expected, and labeling was saturated at 100 μM hydroxylamine. We also verified that the reaction occurs in a time-dependent manner (Figure 4D). Modified lysozyme 15 was treated with hydroxylamine 13 (200 μM) and quenched with N,N-diethylhydroxylamine (20 mM) at various time points. In-gel fluorescence analysis revealed signal saturation by 1 h. We further verified that the desired adducts were formed on the protein by mass spectrometry. Lysozyme 15 was incubated with hydroxylamine 13 (100 μM) in PBS, and the complete conversion of mono- and dicyclooctyne functionalized lysozymes 15 to mono- and dienamine N-oxides 16 was verified by ESI-MS (Figure 4E).

Figure 4.

Figure 4.

Demonstration of protein labeling using the retro-Cope elimination reaction. (A) Synthetic route for fluorophore-hydroxylamine conjugate 13. (B) Lysozyme was modified using NHS-ester 14 to provide cyclooctyne-containing lysozyme 15. The modified protein lysozyme-COT 15 was labeled with fluorescent hydroxylamine 13. (C) In-gel fluorescence analysis of lysozyme-COT 15 (0.14 mg/mL) incubated with various concentrations of hydroxylamine 13 (10–200 μM) in PBS at room temperature for 2 h. (D) In-gel fluorescence analysis of lysozyme-COT 15 (0.14 mg/mL) incubated with hydroxylamine 13 (200 μM) for 1–120 min in PBS at room temperature. (E) Complete conjugation was observed via intact mass spectrometry of lysozyme-fluorophore conjugate 16 obtained by incubation of lysozyme-COT 15 (0.58 mg/mL) and hydroxylamine 13 (200 μM) in PBS at room temperature for 6 h.

We next verified the stability of both the enamine N-oxide and hydroxylamine species under a variety of biologically relevant conditions at various time points (Figure 5A, B). Hydroxylamine 13 was first incubated in PBS at room temperature, and HPLC analysis of the solution indicated that the compound was >86% intact for up to 8 h. Approximately 40% of the hydroxylamine had decomposed by the 24 h time point, however. The primary degradation products were consistent with hydrolysis of the regioisomeric nitrones likely generated by autoxidation. Consequently, we found that this degradation pathway could be abrogated by addition of cellular reductants such as ascorbic acid (5 mM) or glutathione (5 mM).39 Negligible degradation was observed over 24 h. We similarly found that hydroxylamine 13 is stable in HEK293T cell lysate (1 mg/mL), experiencing no degradation above background over 24 h even when unbuffered with exogenous reductants.

Figure 5.

Figure 5.

Demonstration of bioorthogonality. (A) Synthesis of enamine N-oxide 17. (B) The stability of hydroxylamine 13 and enamine N-oxide 17 was studied in PBS at pH 7.4 in the presence of glutathione (5 mM), cell lysate (1 mg/mL), microsomes (0.2 mg/mL), or without additives. The protective effect of sodium ascorbate (5 mM) was additionally evaluated for hydroxylamine 13. (C) In-gel fluorescence analysis of the reaction between hydroxylamine 13 (200 μM) and lysozyme-COT 15 in the presence of cell lysate (2.5 mg/mL) for 2 h showed exclusive labeling of lysozyme. (D) Live cell labeling with mutually orthogonal hydroamination and tetrazine-trans-cyclooctene reactions. HeLa cells transiently co-transfected with cell surface GFP-HaloTag and SNAP-Tag-BFP were treated with COT-chloroalkane (10 μM) and TCO-benzylguanine (10 μM) for 30 min, washed, treated with TAMRA-hydroxylamine (50 μM) and Cy5-tetrazine (1 μM) for 1 h at 37 °C, fixed, then imaged by confocal microscopy. Scale bar = 25 μm.

As with the hydroxylamine, the stability of enamine N-oxide 17 was evaluated by HPLC under biologically relevant conditions. Gratifyingly, it showed no evidence of degradation alone or in the presence of 5 mM glutathione in PBS at room temperature over the course of 24 h. Furthermore, while N-oxides do undergo reduction in a hemeprotein-dependent manner under hypoxic conditions, this process is sufficiently inhibited by aerobic conditions.40 Incubation of enamine N-oxide 17 with human liver microsomes (0.2 mg/mL) under ambient air resulted in negligible degradation after 24 h.

Further demonstrating the bioorthogonality of the reaction, we combined TAMRA-hydroxylamine 13 and lysozyme-COT 15 in the presence and absence of HEK293T cell lysate in PBS for 2 h (Figure 5C). In-gel fluorescence shows that the lysozyme is labeled exclusively and that the degree of labeling is unperturbed by the presence of lysate. There appears to be no cross-reactivity between dialkylhydroxylamine and other proteins under these conditions.

Finally, we decided to explore the cross-compatibility of this reaction with other bioorthogonal systems to identify mutually orthogonal substrate combinations that could be used in tandem (Figures S6-S8).25 We first evaluated whether tetrazines would be compatible with sterically congested cyclooctynes featuring tetrasubstitution at the propargylic position. Indeed, no product could be detected when cyclooctyne ketal 5 and tetrazine S18 were combined at 5 mM concentrations for 1 h in d3-acetonitrile. Uncertain of whether steric constraints imposed by the fully substituted carbon41 or the electronics of the ketal were primarily responsible for inhibiting the inverse-electron demand cycloaddition, we evaluated electron-deficient cyclooctynes 9 and 10 under the same conditions to similar effect. Electronics, alone or in combination with sterics, can render the two reactions orthogonal. Similarly, we also evaluated whether our hydroxylamine reagents would be compatible with strained alkenes. 5 mM N,N-diethylhydroxylamine (1) combined with 5 mM cyclopropene S2142 or trans-cyclooctene S1943 proved unreactive in d3-acetonitrile. We also found that N,N-dialkylhydroxylamines do not react with aldehydes or engage in the copper-catalyzed azide-alkyne cycloaddition.44

Dual labeling of cellular components using mutually orthogonal bioorthogonal reactions was performed on HeLa cells expressing cell surface GFP-HaloTag45 or SNAP-Tag-BFP46 and pre-treated with COT-chloroalkane 18 or TCO-benzylguanine 19 (Figures 5D, S9). Labeling by TAMRA-hydroxylamine 13 or Cy5-tetrazine 20 occurred if and only if cells expressed the corresponding fluorescent protein and were treated with the cognate reagent. Furthermore, intracellular labeling was accomplished in HeLa cells expressing cytosolic GFP-HaloTag using chloroalkane 18 and hydroxylamine 13 (Figure S10).

In this manuscript, we have identified a new bioorthogonal ligation reaction between N,N-dialkylhydroxylamines and cyclooctynes. The reaction features rapid kinetics with second order rate constants as high as 84 M−1s−1, exquisite regioselectivity, and small reaction components. The N,N-dialkylhydroxylamine reagent can be pared down to as few as three non-hydrogen atoms, and the cyclooctyne is likewise supremely effective even when unfunctionalized. Cyclooctynes can be attached conveniently at their propargylic positions without incurring costs to reactivity. We have also demonstrated that the hydroxylamine reagent and enamine N-oxide product are sufficiently stable under aqueous conditions in the presence of thiols or components of the cellular milieu found in the cell lysate, particularly on timescales that are germane to the ligation of small molecules to biomolecules. Both components, however, do have their sensitivities: hydroxylamines to air and enamine N-oxides to microsomes absent oxygen. We have identified factors that mitigate against these processes and ensure the bioorthogonality of the reaction. This retro-Cope elimination reaction adds an orthogonal member to the growing compendium of bioorthogonal reactions and demonstrates that there are yet untapped reaction modalities to be explored. Most importantly, this reaction paves the way for further expansion of our bioorthogonal arsenal’s functional repertoire.

Supplementary Material

Supplementary Information

ACKNOWLEDGMENT

We thank Dr. Scott Ficarro and the DFCI Blais Proteomics Center for assistance with protein mass spectrometry. This research was supported by the NIH NIEHS (1DP2ES030448) and the Claudia Adams Barr Program for Innovative Cancer Research.

Footnotes

Supporting Information. Experimental procedures and characterization data for all compound (PDF). This material is available free of charge via the Internet at http://pubs.acs.org.

The authors declare no competing financial interest.

REFERENCES

  • (1).Sletten EM; Bertozzi CR, Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality. Angew. Chem., Int. Ed 2009, 48, 6974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (2).Parker CG; Pratt MR, Click Chemistry in Proteomic Investigations. Cell 2020, 180, 605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (3).Takayama Y; Kusamori K; Nishikawa M, Click Chemistry as a Tool for Cell Engineering and Drug Delivery. Molecules 2019, 24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (4).Baskin JM; Prescher JA; Laughlin ST; Agard NJ; Chang PV; Miller IA; Lo A; Codelli JA; Bertozzi CR, Copper-free click chemistry for dynamic in vivo imaging. Proc. Natl. Acad. Sci. U.S.A 2007, 104, 16793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).Agard NJ; Bertozzi CR, Chemical Approaches To Perturb, Profile, and Perceive Glycans. Acc. Chem. Res 2009, 42, 788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Cioce A; Malaker SA; Schumann B, Generating orthogonal glycosyltransferase and nucleotide sugar pairs as next-generation glycobiology tools. Curr. Opin. Chem. Biol 2021, 60, 66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Hang HC; Wilson JP; Charron G, Bioorthogonal Chemical Reporters for Analyzing Protein Lipidation and Lipid Trafficking. Acc. Chem. Res 2011, 44, 699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Laguerre A; Schultz C, Novel lipid tools and probes for biological investigations. Curr. Opin. Cell Biol 2018, 53, 97. [DOI] [PubMed] [Google Scholar]
  • (9).Flores J; White BM; Brea RJ; Baskin JM; Devaraj NK, Lipids: chemical tools for their synthesis, modification, and analysis. Chem. Soc. Rev 2020, 49, 4602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).George JT; Srivatsan SG, Bioorthogonal chemistry-based RNA labeling technologies: evolution and current state. Chem. Commun. (Cambridge, U. K.) 2020, 56, 12307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (11).Shih H-W; Prescher JA, A Bioorthogonal Ligation of Cyclopropenones Mediated by Triarylphosphines. J. Am. Chem. Soc 2015, 137, 10036. [DOI] [PubMed] [Google Scholar]
  • (12).Andersen KA; Aronoff MR; McGrath NA; Raines RT, Diazo Groups Endure Metabolism and Enable Chemoselectivity in Cellulo. J. Am. Chem. Soc 2015, 137, 2412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Jewett JC; Sletten EM; Bertozzi CR, Rapid Cu-Free Click Chemistry with Readily Synthesized Biarylazacyclooctynones. J. Am. Chem. Soc 2010, 132, 3688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Darko A; Wallace S; Dmitrenko O; Machovina MM; Mehl RA; Chin JW; Fox JM, Conformationally strained trans-cyclooctene with improved stability and excellent reactivity in tetrazine ligation. Chem. Sci 2014, 5, 3770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Hu Y; Roberts JM; Kilgore HR; Mat Lani AS; Raines RT; Schomaker JM, Triple, Mutually Orthogonal Bioorthogonal Pairs through the Design of Electronically Activated Sulfamate-Containing Cycloalkynes. J. Am. Chem. Soc 2020, 142, 18826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (16).Row RD; Shih H-W; Alexander AT; Mehl RA; Prescher JA, Cyclopropenones for Metabolic Targeting and Sequential Bioorthogonal Labeling. J. Am. Chem. Soc 2017, 139, 7370. [DOI] [PubMed] [Google Scholar]
  • (17).Tu J; Svatunek D; Parvez S; Liu AC; Levandowski BJ; Eckvahl HJ; Peterson RT; Houk KN; Franzini RM, Stable, Reactive, and Orthogonal Tetrazines: Dispersion Forces Promote the Cycloaddition with Isonitriles. Angew. Chem., Int. Ed 2019, 58, 9043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Gröst C; Berg T, PYRROC: the first functionalized cycloalkyne that facilitates isomer-free generation of organic molecules by SPAAC. Org. Biomol. Chem 2015, 13, 3866. [DOI] [PubMed] [Google Scholar]
  • (19).Völker T; Dempwolff F; Graumann PL; Meggers E, Progress towards Bioorthogonal Catalysis with Organometallic Compounds. Angew. Chem., Int. Ed 2014, 53, 10536. [DOI] [PubMed] [Google Scholar]
  • (20).Li J; Chen PR, Development and application of bond cleavage reactions in bioorthogonal chemistry. Nat. Chem. Biol 2016, 12, 129. [DOI] [PubMed] [Google Scholar]
  • (21).Versteegen RM; ten Hoeve W; Rossin R; de Geus MAR; Janssen HM; Robillard MS, Click-to-Release from trans-Cyclooctenes: Mechanistic Insights and Expansion of Scope from Established Carbamate to Remarkable Ether Cleavage. Angew. Chem., Int. Ed 2018, 57, 10494. [DOI] [PubMed] [Google Scholar]
  • (22).Carlson JCT; Mikula H; Weissleder R, Unraveling Tetrazine-Triggered Bioorthogonal Elimination Enables Chemical Tools for Ultrafast Release and Universal Cleavage. J. Am. Chem. Soc 2018, 140, 3603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Ji X; Pan Z; Yu B; De La Cruz LK; Zheng Y; Ke B; Wang B, Click and release: bioorthogonal approaches to “on-demand” activation of prodrugs. Chem. Soc. Rev 2019, 48, 1077. [DOI] [PubMed] [Google Scholar]
  • (24).Liang Y; Mackey JL; Lopez SA; Liu F; Houk KN, Control and Design of Mutual Orthogonality in Bioorthogonal Cycloadditions. J. Am. Chem. Soc 2012, 134, 17904. [DOI] [PubMed] [Google Scholar]
  • (25).Patterson DM; Prescher JA, Orthogonal bioorthogonal chemistries. Curr. Opin. Chem. Biol 2015, 28, 141. [DOI] [PubMed] [Google Scholar]
  • (26).Row RD; Prescher JA, Constructing New Bioorthogonal Reagents and Reactions. Acc. Chem. Res 2018, 51, 1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).Devaraj NK, The Future of Bioorthogonal Chemistry. ACS Cent. Sci 2018, 4, 952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).Bourgeois J; Dion I; Cebrowski PH; Loiseau F; Bédard A-C; Beauchemin AM, The Tandem Cope-Type Hydroamination/[2,3]-Rearrangement Sequence: A Strategy to Favor the Formation of Intermolecular Hydroamination Products and Enable Difficult Cyclizations. J. Am. Chem. Soc 2009, 131, 874. [DOI] [PubMed] [Google Scholar]
  • (29).Beauchemin AM, Recent developments in Cope-type hydroamination reactions of hydroxylamine and hydrazine derivatives. Org. Biomol. Chem 2013, 11, 7039. [DOI] [PubMed] [Google Scholar]
  • (30).O'Neil IA; McConville M; Zhou K; Brooke C; Robertson CM; Berry NG, The synthesis and structure of chiral enamine N-oxides. Chem. Commun. (Cambridge, U. K.) 2014, 50, 7336. [DOI] [PubMed] [Google Scholar]
  • (31).Zhao Y; Truhlar DG, The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor. Chem. Acc 2008, 120, 215. [Google Scholar]
  • (32).Dommerholt J; Schmidt S; Temming R; Hendriks LJA; Rutjes FPJT; van Hest JCM; Lefeber DJ; Friedl P; van Delft FL, Readily Accessible Bicyclononynes for Bioorthogonal Labeling and Three-Dimensional Imaging of Living Cells. Angew. Chem., Int. Ed 2010, 49, 9422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Agard NJ; Baskin JM; Prescher JA; Lo A; Bertozzi CR, A Comparative Study of Bioorthogonal Reactions with Azides. ACS Chem. Biol 2006, 1, 644. [DOI] [PubMed] [Google Scholar]
  • (34).Ess DH; Jones GO; Houk KN, Transition States of Strain-Promoted Metal-Free Click Chemistry: 1,3-Dipolar Cycloadditions of Phenyl Azide and Cyclooctynes. Org. Lett 2008, 10, 1633. [DOI] [PubMed] [Google Scholar]
  • (35).Liu F; Liang Y; Houk KN, Bioorthogonal Cycloadditions: Computational Analysis with the Distortion/Interaction Model and Predictions of Reactivities. Acc. Chem. Res 2017, 50, 2297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (36).Agard NJ; Prescher JA; Bertozzi CR, A Strain-Promoted [3 + 2] Azide–Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living Systems. J. Am. Chem. Soc 2004, 126, 15046. [DOI] [PubMed] [Google Scholar]
  • (37).Debets MF; van Berkel SS; Schoffelen S; Rutjes FPJT; van Hest JCM; van Delft FL, Aza-dibenzocyclooctynes for fast and efficient enzyme PEGylation via copper-free (3+2) cycloaddition. Chem. Commun. (Cambridge, U. K.) 2010, 46, 97. [DOI] [PubMed] [Google Scholar]
  • (38).Kim EJ; Kang DW; Leucke HF; Bond MR; Ghosh S; Love DC; Ahn J-S; Kang D-O; Hanover JA, Optimizing the selectivity of DIFO-based reagents for intracellular bioorthogonal applications. Carbohydr. Res 2013, 377, 18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (39).Bobko AA; Kirilyuk IA; Grigor’ev IA; Zweier JL; Khramtsov VV, Reversible reduction of nitroxides to hydroxylamines: Roles for ascorbate and glutathione. Free Radical Biol. Med 2007, 42, 404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (40).Raleigh SM; Wanogho E; Burke MD; McKeown SR; Patterson LH, Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone DI-N-oxide prodrug. Int. J. Radiat. Oncol. Biol. Phys 1998, 42, 763. [DOI] [PubMed] [Google Scholar]
  • (41).Liu F; Liang Y; Houk KN, Theoretical Elucidation of the Origins of Substituent and Strain Effects on the Rates of Diels–Alder Reactions of 1,2,4,5-Tetrazines. J. Am. Chem. Soc 2014, 136, 11483. [DOI] [PubMed] [Google Scholar]
  • (42).Patterson DM; Nazarova LA; Xie B; Kamber DN; Prescher JA, Functionalized Cyclopropenes As Bioorthogonal Chemical Reporters. J. Am. Chem. Soc 2012, 134, 18638. [DOI] [PubMed] [Google Scholar]
  • (43).Blackman ML; Royzen M; Fox JM, Tetrazine Ligation: Fast Bioconjugation Based on Inverse-Electron-Demand Diels–Alder Reactivity. J. Am. Chem. Soc 2008, 130, 13518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (44).Hein JE; Fokin VV, Copper-catalyzed azide–alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(i) acetylides. Chem. Soc. Rev 2010, 39, 1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (45).Los GV; Encell LP; McDougall MG; Hartzell DD; Karassina N; Zimprich C; Wood MG; Learish R; Ohana RF; Urh M; Simpson D; Mendez J; Zimmerman K; Otto P; Vidugiris G; Zhu J; Darzins A; Klaubert DH; Bulleit RF; Wood KV, HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis. ACS Chem. Biol 2008, 3, 373. [DOI] [PubMed] [Google Scholar]
  • (46).Keppler A; Gendreizig S; Gronemeyer T; Pick H; Vogel H; Johnsson K, A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat. Biotechnol 2003, 21, 86. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information

RESOURCES